[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

U.S. & Canada Skin Cancer Dermatology Market Size, Share & Trends Analysis Report By Test Type (Skin Biopsy, Dermatoscopy), By Facility Type (Stand-alone, Hospitals), By Age Group, And Segment Forecasts, 2020 - 2027

May 2020 | 116 pages | ID: U5F013A2DF6BEN
Grand View Research, Inc.

US$ 5,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
U.S. & Canada Skin Cancer Dermatology Market Growth & Trends

The U.S. and Canada skin cancer dermatology market size is expected to reach around a value of USD 2.2 billion and 0.7 billion respectively by 2027, according to a new report by Grand View Research, Inc. The markets are anticipated to register a CAGR of 5.2% and 6.3% respectively, during the forecast period. Technological advancements and increasing prevalence of skin cancer are anticipated to fuel the growth.

The growing usage of smartphones and the development of smartphone compatible dermatoscopes are the factors anticipated to fuel the market growth. According to the Canadian Radio-television and Telecommunications Commission data, the percentage of Canadians using a smartphone increased from 73% in 2015 to 78% in 2017, thus indicating high potential for teledermatology in the country.

In addition, ongoing research activities for advancements in the dermatology field are anticipated to drive the growth of the market in U.S and Canada. For instance, according to the study published by Nature Journal, Deep Convolutional Neural Networks (CNN) classified the various skin cancers with a competence level comparable to a dermatologist, thus highlighting the potential of Artificial Intelligence (AI) in the field of dermatology.

Inappropriate use of ABCD criteria by Medical necessity auditors is one of the major concerns of dermatologists. For instance, some of the melanoma positive biopsies have been ruled as ‘medically unnecessary’ due to lack of medical documentation of ABCD or signs and symptoms. The ABCD tool was primarily designed for public education and not an important aspect of the physician’s note.

U.S. & Canada Skin Cancer Dermatology Market Report Highlights
  • Skin biopsy is the most widely used test for skin cancer and thus, accounted for the largest market share in 2019
  • Diagnostic imaging is anticipated to witness rapid growth over the forecast period due to the introduction of advanced imaging and non-invasive diagnostic techniques
  • The 40-59 segment held the largest market share in 2019 while the 20-39 segment is anticipated to witness lucrative growth over the forecast period
  • Teledermatology programs such as DermaGO, ACCESSDERM are anticipated to improve patient access in the U.S. and Canada
  • Hospital OPD segment held a significant share of the U.S. and Canada skin cancer dermatology market in 2019 owing to the presence of public insurance systems is expected to enhance the patient influx in this setting
  • Age and gender of the dermatologists significantly affect the type of practice, practice location and work hours.
  • Some of the key market players are Firefly; SkinIO, Canfield Scientific, Inc., FotoFinder Systems, Inc., 3Gen, MetaOptima, Agilent Technologies, SkinVision, Speclipse, Inc., Skin Analytics.
CHAPTER 1 METHODOLOGY AND SCOPE

1.1 Segment Market Scope
1.2 Estimates and Forecast Timeline
1.3 Research Methodology
  1.3.1 Information procurement
  1.3.2 Purchased database:
  1.3.3 GVR’s Internal Database
  1.3.4 Secondary sources:
  1.3.5 Primary Research:
1.4 List of Primary Sources
1.5 Information Or Data Analysis
1.6 Market Formulation & Validation
1.7 Model Details
  1.7.1 Approach 1: Bottom up Approach
  1.7.2 Approach 2: Procedure Volume Approach
1.8 Objectives
  1.8.1 Objective 1:
  1.8.2 Objective 2:

CHAPTER 2 EXECUTIVE SUMMARY

2.1 Market Outlook

CHAPTER 3 MARKET VARIABLES, TRENDS & SCOPE

3.1 Market Segmentation
3.2 U.S. Market Variable Analysis
  3.2.1 Market driver analysis
    3.2.1.1 Increase in the prevalence of skin cancer
    3.2.1.2 Exposure to ultraviolet radiation
    3.2.1.3 Constant technological advancements in skin cancer diagnostic tests
3.3 Canada Market Variable Analysis
  3.3.1 Market driver analysis
    3.3.1.1 Increasing incidence of melanoma in Canada
    3.3.1.2 Technological advancements
    3.3.1.3 Increasing awareness campaigns and supportive government initiatives
  3.3.2 U.S. Market restraint analysis
    3.3.2.1 Lack of universal health coverage
  3.3.3 Canada Market restraint analysis
    3.3.3.1 Shortage of medical resources and limited access to healthcare.
3.4 Penetration & Growth Prospect Mapping
  3.4.1 U.S. Penetration & Growth Prospect Mapping, By Test Type
  3.4.2 Canada Penetration & Growth Prospect Mapping, By Test Type
3.5 Business Environment Analysis tools
  3.5.1 SWOT Analysis, by PEST
  3.5.2 Porter’s five forces analysis
  3.5.3 U.S. & Canada Dermatology Market: Competitive insight
    3.5.3.1 Role of concierge medicine/boutique medicine in the dermatology space
    3.5.3.2 Advantages of Concierge Medicine:
    3.5.3.3 Disadvantages of Concierge Medicine:
    3.5.3.4 Role of nurse practitioners and physician assistants in the value chain of skin cancer screening
    3.5.3.5 Technological Advancements
    3.5.3.6 Decision support systems & Dermatology software
    3.5.3.7 Artificial intelligence in dermatology
    3.5.3.8 Applications:

CHAPTER 4 U.S. DERMATOLOGY MARKET: SEGMENT ANALYSIS BY TEST TYPE

4.1 U.S. Dermatology Market: Test Type Movement Analysis
4.2 Skin Biopsy
  4.2.1 Skin Biopsy market estimates and forecasts, 2016 - 2027 (USD Million)
4.3 Dermatoscopy
  4.3.1 Dermatoscopy market estimates and forecasts, 2016 - 2027 (USD Million)
4.4 Diagnostic Imaging
  4.4.1 Diagnostic imaging market estimates and forecasts, 2016 - 2027 (USD Million)
4.5 Lymph Node Biopsy
  4.5.1 Lymph Node Biopsy market estimates and forecasts, 2016 - 2027 (USD Million)

CHAPTER 5 CANADA DERMATOLOGY MARKET: SEGMENT ANALYSIS BY TEST TYPE

5.1 Canada Dermatology Market: Test Type Movement Analysis
5.2 Skin Biopsy
  5.2.1 Skin Biopsy market estimates and forecasts, 2016 - 2027 (USD Million)
5.3 Dermatoscopy
  5.3.1 Dermatoscopy market estimates and forecasts, 2016 - 2027 (USD Million)
5.4 Diagnostic Imaging
  5.4.1 Diagnostic imaging market estimates and forecasts, 2016 - 2027 (USD Million)
5.5 Lymph Node Biopsy
  5.5.1 Lymph Node Biopsy market estimates and forecasts, 2016 - 2027 (USD Million)

CHAPTER 6 U.S. DERMATOLOGY MARKET: SEGMENT ANALYSIS BY FACILITY TYPE

6.1 U.S. Dermatology Market: Facility Type Movement Analysis
6.2 Standalone Practices
  6.2.1 Standalone Practices market estimates and forecasts, 2016 - 2027 (USD Million)
6.3 Multispecialty Clinics
  6.3.1 Multispecialty Clinics market estimates and forecasts, 2016 - 2027 (USD Million)
6.4 Dermatology Groups
  6.4.1 Dermatology Groups market estimates and forecasts, 2016 - 2027 (USD Million)
6.5 Hospital Outpatient Departments
  6.5.1 Hospital Outpatient Departments market estimates and forecasts, 2016 - 2027 (USD Million)
6.6 Others (Integrated Delivery Network)
  6.6.1 Others (Integrated Delivery Network) market estimates and forecasts, 2016 - 2027 (USD Million)

CHAPTER 7 CANADA DERMATOLOGY MARKET: SEGMENT ANALYSIS BY FACILITY TYPE

7.1 Canada Dermatology Market: Facility Type Movement Analysis
7.2 Standalone Practices
  7.2.1 Standalone Practices market estimates and forecasts, 2016 - 2027 (USD Million)
7.3 Multispecialty Clinics
  7.3.1 Multispecialty Clinics market estimates and forecasts, 2016 - 2027 (USD Million)
7.4 Dermatology Groups
  7.4.1 Dermatology Groups market estimates and forecasts, 2016 - 2027 (USD Million)
7.5 Hospital Outpatient Departments
  7.5.1 Hospital Outpatient Departments market estimates and forecasts, 2016 - 2027 (USD Million)
7.6 Others (Integrated Delivery Network)
  7.6.1 Others (Integrated Delivery Network) market estimates and forecasts, 2016 - 2027 (USD Million)

CHAPTER 8 U.S. DERMATOLOGY MARKET: SEGMENT ANALYSIS BY AGE-GROUP

8.1 U.S. Dermatology Market: Age-group Movement Analysis
8.2 0-19
  8.2.1 0-19 market estimates and forecasts, 2016 - 2027 (USD Million)
  8.2.2 Male 0-19 market estimates and forecasts, 2016 - 2027 (USD Million)
  8.2.3 Female 0-19 market estimates and forecasts, 2016 - 2027 (USD Million)
8.3 20-39
  8.3.1 20-39 Market estimates and forecasts, 2016 - 2027 (USD Million)
  8.3.2 Male 20-39 market estimates and forecasts, 2016 - 2027 (USD Million)
  8.3.3 Female 20-39 market estimates and forecasts, 2016 - 2027 (USD Million)
8.4 40-59
  8.4.1 40-59 Market estimates and forecasts, 2016 - 2027 (USD Million)
  8.4.2 Male 40-59 market estimates and forecasts, 2016 - 2027 (USD Million)
  8.4.3 Female 40-59 market estimates and forecasts, 2016 - 2027 (USD Million)
8.5 60-64
  8.5.1 60-64 Market estimates and forecasts, 2016 - 2027 (USD MILLION)
  8.5.2 Male 60-64 market estimates and forecasts, 2016 - 2027 (USD Million)
  8.5.3 Female 60-64 market estimates and forecasts, 2016 - 2027 (USD Million)
8.6 65-74
  8.6.1 65-74 Market ESTIMATES AND FORECASTS, 2016 - 2027 (USD Million)
  8.6.2 Male 65-74 market estimates and forecasts, 2016 - 2027 (USD Million)
  8.6.3 Female 65-74 market estimates and forecasts, 2016 - 2027 (USD Million)
8.7 75-84
  8.7.1 75-84 Market estimates and forecasts, 2016 - 2027 (USD Million)
  8.7.2 Male 75-84 market estimates and forecasts, 2016 - 2027 (USD Million)
  8.7.3 Female 75-84 market estimates and forecasts, 2016 - 2027 (USD Million)
8.8 85 & above
  8.8.1 85 & above Market estimates and forecasts, 2016 - 2027 (USD Million)
  8.8.2 Male 85 & above market estimates and forecasts, 2016 - 2027 (USD Million)
  8.8.3 Female 85 & above market estimates and forecasts, 2016 - 2027 (USD Million)

CHAPTER 9 CANADA DERMATOLOGY MARKET: SEGMENT ANALYSIS BY AGE-GROUP

9.1 Canada Dermatology Market: Age-group Movement Analysis
9.2 0-19
  9.2.1 0-19 market estimates and forecasts, 2016 - 2027 (USD Million)
  9.2.2 Male 0-19 market estimates and forecasts, 2016 - 2027 (USD Million)
  9.2.3 Female 0-19 market estimates and forecasts, 2016 - 2027 (USD Million)
9.3 20-39
  9.3.1 20-39 Market estimates and forecasts, 2016 - 2027 (USD Million)
  9.3.2 Male 20-39 market estimates and forecasts, 2016 - 2027 (USD Million)
  9.3.3 Female 20-39 market estimates and forecasts, 2016 - 2027 (USD Million)
9.4 40-59
  9.4.1 40-59 Market estimates and forecasts, 2016 - 2027 (USD Million)
  9.4.2 Male 40-59 market estimates and forecasts, 2016 - 2027 (USD Million)
  9.4.3 Female 40-59 market estimates and forecasts, 2016 - 2027 (USD Million)
9.5 60-64
  9.5.1 60-64 Market estimates and forecasts, 2016 - 2027 (USD Million)
  9.5.2 Male 60-64 market estimates and forecasts, 2016 - 2027 (USD Million)
  9.5.3 Female 60-64 market estimates and forecasts, 2016 - 2027 (USD Million)
9.6 65-74
  9.6.1 65-74 Market estimates and forecasts, 2016 - 2027 (USD Million)
  9.6.2 Male 65-74 market estimates and forecasts, 2016 - 2027 (USD Million)
  9.6.3 Female 65-74 market estimates and forecasts, 2016 - 2027 (USD Million)
9.7 75-84
  9.7.1 75-84 Market estimates and forecasts, 2016 - 2027 (USD Million)
  9.7.2 Male 75-84 market estimates and forecasts, 2016 - 2027 (USD Million)
  9.7.3 Female 75-84 market estimates and forecasts, 2016 - 2027 (USD Million)
9.8 85 & above
  9.8.1 85 & above market estimates and forecasts, 2016 - 2027 (USD Million)
  9.8.2 Male 85 & above market estimates and forecasts, 2016 - 2027 (USD Million)
  9.8.3 Female 85 & above market estimates and forecasts, 2016 - 2027 (USD Million)

CHAPTER 10 COMPETITIVE ANALYSIS

10.1 Company Profiles
  10.1.1 Firefly
    10.1.1.1 Company overview
    10.1.1.2 Financial performance
    10.1.1.3 Product Benchmarking
  10.1.2 SkinIO
    10.1.2.1 Company overview
    10.1.2.2 Financial performance
    10.1.2.3 Product Benchmarking
    10.1.2.4 Strategic Initiative
  10.1.3 Canfield Scientific, Inc.
    10.1.3.1 Company overview
    10.1.3.2 Financial performance
    10.1.3.3 Product Benchmarking
    10.1.3.4 Strategic Initiative
  10.1.4 FotoFinder Systems, Inc.
    10.1.4.1 Company overview
    10.1.4.2 Financial performance
    10.1.4.3 Product Benchmarking
  10.1.5 3GEN
    10.1.5.1 Company overview
    10.1.5.2 Financial performance
    10.1.5.3 Product Benchmarking
  10.1.6 MetaOptima
    10.1.6.1 Company overview
    10.1.6.2 Financial performance
    10.1.6.3 Product Benchmarking
    10.1.6.4 Strategic Initiative
  10.1.7 Agilent Technologies
    10.1.7.1 Company overview
    10.1.7.2 Financial performance
    10.1.7.3 Product Benchmarking
    10.1.7.4 Strategic Initiative
  10.1.8 SkinVision
    10.1.8.1 Company overview
    10.1.8.2 Financial performance
    10.1.8.3 Product Benchmarking
  10.1.9 Speclipse, INC.
    10.1.9.1 Company overview
    10.1.9.2 Financial performance
    10.1.9.3 Product Benchmarking
  10.1.10 Skin Analytics
    10.1.10.1 Company overview
    10.1.10.2 Financial performance
    10.1.10.3 Product Benchmarking

LIST OF TABLES

Table 1 List of secondary sources
Table 2 U.S. skin cancer dermatology market, by facility type, 2016 - 2027 (USD Million)
Table 3 U.S. skin cancer dermatology market, by test type, 2016 - 2027 (USD Million)
Table 4 U.S. skin cancer dermatology market, by age group, 2016 - 2027 (USD Million)
Table 5 Canada skin cancer dermatology market, by facility type, 2016 - 2027 (USD Million)
Table 6 Canada skin cancer dermatology market, by test type, 2016 - 2027 (USD Million)
Table 7 Canada skin cancer dermatology market, by age group, 2016 - 2027 (USD Million)
LIST OF FIGURES

Fig. 1 Market research process
Fig. 2 Information Procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 U.S. Dermatology market snapshot (2019)
Fig. 9 Canada Dermatology market snapshot (2019)
Fig. 10 Dermatology market segmentation
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market driver relevance analysis (Current & future impact)
Fig. 13 Market restraint relevance analysis (Current & future impact)
Fig. 14 Market restraint relevance analysis (Current & future impact)
Fig. 15 Penetration & growth prospect mapping, by test type
Fig. 16 Penetration & growth prospect mapping, by test type
Fig. 17 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 18 Porter’s five forces analysis
Fig. 19 Dermatology market test type outlook: Key takeaways
Fig. 20 U.S. Dermatology market: Test type movement analysis
Fig. 21 Skin biopsy market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 22 Dermatoscopy market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 23 Diagnostic imaging market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 24 Lymph node biopsy market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 25 Dermatology market test type outlook: Key takeaways
Fig. 26 Canada Dermatology market: Test type movement analysis
Fig. 27 Skin biopsy market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 28 Dermatoscopy market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 29 Diagnostic imaging market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 30 Lymph node biopsy market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 31 Dermatology market facility type outlook: Key takeaways
Fig. 32 U.S. Dermatology market: facility type movement analysis
Fig. 33 Standalone practices market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 34 Multispecialty Clinics market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 35 Dermatology Groups market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 36 Hospital outpatient departments market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 37 Others (Integrated Delivery Network) market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 38 Dermatology market facility type outlook: Key takeaways
Fig. 39 Canada Dermatology market: facility type movement analysis
Fig. 40 Standalone practices market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 41 Multispecialty Clinics market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 42 Dermatology Groups market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 43 Hospital outpatient departments market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 44 Others (Integrated Delivery Network) market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 45 Dermatology market age-group outlook: Key takeaways
Fig. 46 U.S. Dermatology market: age-group movement analysis
Fig. 47 0-19 market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 48 Male 0-19 market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 49 Female 0-19 market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 50 20-39 market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 51 Male 20-39 market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 52 Female 0-19 market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 53 40-59 market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 54 Male 40-59 market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 55 Female 40-59 market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 56 60-64 market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 57 Male 60-64 market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 58 Female 60-64 market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 59 65-74 market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 60 Male 65-74 market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 61 Female 65-74 market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 62 75-84 market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 63 Male 75-84 market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 64 Female 75-84 market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 65 85 & above market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 66 Male 85 & above market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 67 Female 85 & above market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 68 Dermatology market age-group outlook: Key takeaways
Fig. 69 Canada Dermatology market: age-group movement analysis
Fig. 70 0-19 market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 71 Male 0-19 market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 72 Female 0-19 market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 73 20-39 market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 74 Male 20-39 market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 75 Female 0-19 market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 76 40-59 market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 77 Male 40-59 market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 78 Female 40-59 market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 79 60-64 market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 80 Male 60-64 market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 81 Female 60-64 market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 82 65-74 market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 83 Male 65-74 market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 84 Female 65-74 market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 85 75-84 market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 86 Male 75-84 market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 87 Female 75-84 market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 88 85 & above market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 89 Male 85 & above market estimates and forecasts, 2016 - 2027 (USD Million)
Fig. 90 Female 85 & above market estimates and forecasts, 2016 - 2027 (USD Million)


More Publications